Friday Satellite Symposia
Diseases
Grand Ballroom, 4
(Omni San Diego)
Chair:
Neil Love, MD, Research To Practice
Disclosures:
No relevant conflicts of interest to declare.
Speakers:
Michael Dickinson, MBBS, D. Med Sci, FRACP, FRCPA, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital
,
Grzegorz S. Nowakowski, MD, Mayo Clinic
,
Gilles Salles, MD, PhD, Memorial Sloan Kettering Cancer Center
,
Laurie H. Sehn, MD, MPH, BC Cancer Centre for Lymphoid Cancer and The University of British Columbia
and
Jason Westin, MD, The University of Texas M D Anderson Cancer Center
Disclosures:
Dickinson: F. Hoffmann-La Roche Ltd: Other: travel, accommodation, expenses; F. Hoffmann-La Roche Ltd, Amgen, MSD, Janssen, Bristol-Myers Squibb, Novartis, Gilead Sciences, Abbvie: Honoraria; Novartis, F. Hoffmann-La Roche Ltd, Takeda, Celgene, MSD, Abbvie, Lilly: Research Funding; Novartis, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, Gilead Sciences, Janssen, Abbvie, Genmab: Consultancy. Nowakowski: MEI Pharma: Consultancy; Selvita Inc: Consultancy; Zai Lab Limited: Consultancy; MorphoSys: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Seagen: Consultancy; Kymera Therapeutics: Consultancy; Blueprint Medicines: Consultancy; Celgene Corporation: Consultancy; Bristol-Myers Squibb: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; ADC Therapeutics: Consultancy; Fate Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees; Curis: Consultancy; Abbvie: Consultancy; Bantam Pharmaceutical LLC: Consultancy; Ryvu Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees; TG Therapeutics: Consultancy; Debiopharm: Consultancy; F Hoffmann-La Roche Limited: Consultancy; Genentech: Consultancy; Incyte: Consultancy; Karyopharm Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees; Kite Pharma: Consultancy. Sehn: AbbVie Inc, AstraZeneca Pharmaceuticals LP, BeiGene Ltd, Bristol-Myers Squibb Company, Genentech, a member of the Roche Group, Incyte Corporation, Janssen Biotech Inc, Kite, A Gilead Company, Merck, Seagen Inc, Takeda Pharmaceuticals USA Inc, TG Therapeut: Other: Consulting Agreements; Genentech, a member of the Roche Group, Teva Oncology.: Other: Contracted Research. Westin: Kymera: Research Funding; Novartis: Consultancy, Research Funding; Genentech: Consultancy, Research Funding; Kite/Gilead: Consultancy, Research Funding; MonteRosa: Consultancy; Morphosys/Incyte: Consultancy, Research Funding; Calithera: Research Funding; BMS: Consultancy, Research Funding; AstraZeneca: Consultancy, Research Funding; ADC Therapeutics: Consultancy, Research Funding; Abbvie: Consultancy; SeaGen: Consultancy; Nurix: Consultancy.
On Demand program will be available here soon. For questions, please reach out to the managing company contact from Research to Practice, listed below.
This CME-accredited program, offered for in-person and virtual attendees, will focus on the management of patients with Diffuse Large B-Cell Lymphoma. Four investigators will serve as faculty and the program will be moderated by Dr Neil Love, president of Research To Practice (RTP). Prior to the program, RTP will recruit 15 clinical investigators, who, in addition to the participating faculty, will be asked to complete a case-based survey intended to illuminate their general practice patterns.
At the live event, for each module, Dr Love will present results from the case-based survey and the faculty members on stage will then be asked to register their level of agreement/disagreement with their colleagues’ answers and provide perspectives on their own responses. Each faculty member will also deliver a brief PPT presentation focused on reviewing recently published research data and ongoing clinical trials. Clinicians in attendance (both in person and virtually) will have the opportunity to provide feedback on the same survey and present their own questions for discussion with the faculty.
denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.